Celldex Therapeutics Overview
Celldex Therapeutics Target Price
Analysts' 12-month price predictions for CLDX.
Get informed when a big investor buys or sells
+ FollowShare Price
$29.77
Average Target Price
$49.00
64.6% upside
64.6% upside3 analysts in the last 4 months
High: $54 | Low: $45
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2026-05-13 | Wells FargoDerek Archila | $54 | 81.4% upside |  |
| 2026-05-08 | Barclays | $48 | 61.2% upside | |
| 2026-04-20 | Barclays | $45 | 51.2% upside | |
| 2025-12-17 | Barclays | $24 |  19.4% downside | |
| 2025-11-11 | Barclays | $21 | 29.5% downside | |
| 2025-10-13 | Barclays | $25 | 16% downside | |
| 2025-03-20 | Morgan Stanley | $46 | 54.5% upside | |
| 2024-10-29 | H.C. WainwrightJoseph Pantginis | $80 | 168.7% upside | |
| 2024-09-25 | Wells FargoDerek Archila | $44 | 47.8% upside | |
| 2024-06-17 | Stifel NicolausAlex Thompson | $58 | 94.8% upside | |
| 2023-11-10 | Wells FargoDerek Archila | $27 | 9.3% downside | |
| 2022-11-11 | Guggenheim | $63 | 111.6% upside | |